Analysis

Zentalis Pharmaceuticals, Inc. (ZNTL) Stock Analysis

Zentalis Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ZNTL.

websiteZNTL/analysis/ZNTL

Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ZNTL.

Stock profile

Ticker

ZNTL

Asset type

Stock

Market cap

$263.4M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Zentalis Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • ZNTL primary listing

Latest Zentalis Pharmaceuticals, Inc. news

Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commerci...

Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azeno...

In an all-comer PROC population, across multiple dose cohorts, manageable safety profile of the combination was observed with low frequency of high-grade adverse eventsActivity ...

Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress

Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Plati...

Global Phase 3, randomized, controlled trial comparing azenosertib to standard-of-care chemotherapy now enrollingASPENOVA designed as confirmatory study to support DENALI Phase ...

Zentalis Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(4)

Zentalis Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule

Research sections

Valuation

Review valuation context for Zentalis Pharmaceuticals, Inc..

Future growth

Review future growth context for Zentalis Pharmaceuticals, Inc..

Past performance

Review past performance context for Zentalis Pharmaceuticals, Inc..

Financial health

Review financial health context for Zentalis Pharmaceuticals, Inc..

Dividend

Review dividend context for Zentalis Pharmaceuticals, Inc..

Management

Review management context for Zentalis Pharmaceuticals, Inc..

Ownership

Review ownership context for Zentalis Pharmaceuticals, Inc..

Other information

Review other information context for Zentalis Pharmaceuticals, Inc..

Community

Review community context for Zentalis Pharmaceuticals, Inc..